GITNUXREPORT 2026

Chd Statistics

CHD is a widespread global health crisis affecting millions worldwide.

Rajesh Patel

Team Lead & Senior Researcher with over 15 years of experience in market research and data analytics.

First published: Feb 13, 2026

Our Commitment to Accuracy

Rigorous fact-checking · Reputable sources · Regular updatesLearn more

Statistic 1

US spends $219 billion annually on CHD

Statistic 2

Global CVD economic burden $1 trillion/year, half from CHD

Statistic 3

Lost productivity from CHD: $101 billion/year in US

Statistic 4

CABG costs average $123,000 per patient in US

Statistic 5

PCI procedure costs $20,000-$50,000

Statistic 6

Medicare CHD spending $80 billion/year

Statistic 7

Work absenteeism from CHD: 5.5 million lost days/year UK

Statistic 8

Informal caregiving for CHD patients costs $30 billion/year US

Statistic 9

Disability claims from CHD: 20% of all cardiovascular

Statistic 10

Hospitalizations for CHD: 1.2 million/year US, costing $75 billion

Statistic 11

Low-income CHD patients have 2x higher hospitalization rates

Statistic 12

Gender pay gap widens post-CHD by 10-20% for women

Statistic 13

CHD reduces life expectancy by 5-10 years

Statistic 14

Social isolation increases CHD hospitalization by 68%

Statistic 15

Employer costs for employee CHD: $1,500 higher annually

Statistic 16

Global CHD productivity losses $3.7 trillion 2011-2030

Statistic 17

Nursing home admissions post-CHD double costs by $50,000/year

Statistic 18

Racial disparities: Black CHD costs 25% higher per case

Statistic 19

Telemedicine for CHD saves $2,000 per patient annually

Statistic 20

Smoking-related CHD costs $184 billion/year US

Statistic 21

Obesity-attributable CHD costs $192 billion/year globally

Statistic 22

Cardiac rehab ROI: $2.33 saved per $1 spent

Statistic 23

Statins prevent $13,000 cost per MI avoided

Statistic 24

Aspirin therapy saves $20-40 per patient/year

Statistic 25

In the US, CHD caused 382,897 deaths in 2022, accounting for 1 in 5 deaths

Statistic 26

Globally, ischemic heart disease mortality is 16% of all deaths, or 9 million annually

Statistic 27

Post-myocardial infarction 1-year mortality is 10-15% in developed countries

Statistic 28

US men have age-adjusted CHD death rate of 90.9 per 100,000, women 55.8

Statistic 29

In low-income countries, CHD mortality is rising 2% per year

Statistic 30

Heart failure post-CHD affects 6.2 million US adults, with 50% 5-year mortality

Statistic 31

Recurrent MI occurs in 10-20% within 1 year post-event

Statistic 32

CHD patients have 2-4 times higher stroke risk

Statistic 33

In-hospital mortality for STEMI is 5-10%, NSTEMI 3-5%

Statistic 34

Black Americans have 30% higher CHD mortality than Whites

Statistic 35

Global disability-adjusted life years (DALYs) from ischemic heart disease: 182 million

Statistic 36

5-year survival post-CHD diagnosis is 80-90% with treatment

Statistic 37

Women with CHD have 50% higher mortality post-MI than men

Statistic 38

Rural US CHD mortality 20% higher than urban

Statistic 39

Untreated hypertension leads to 50% CHD mortality increase

Statistic 40

Sudden cardiac death accounts for 50% of CHD deaths

Statistic 41

Post-CABG 10-year mortality is 20-30%

Statistic 42

Diabetes doubles CHD mortality risk

Statistic 43

Age 75+ has CHD mortality rate >500 per 100,000

Statistic 44

Global CHD years of life lost (YLL): 197 million annually

Statistic 45

PCI in-hospital mortality <1% for elective, 2-3% urgent

Statistic 46

Chronic total occlusion increases annual mortality by 2-3%

Statistic 47

Multi-vessel disease mortality 2x single-vessel

Statistic 48

Smoking cessation reduces CHD mortality by 36% in 5 years

Statistic 49

Left ventricular ejection fraction <35% post-MI: 20-40% 1-year mortality

Statistic 50

Atrial fibrillation in CHD patients doubles mortality risk

Statistic 51

PCI vs medical therapy mortality similar at 5 years (16.7% vs 18.2%)

Statistic 52

CABG 30-day mortality 2-3%

Statistic 53

STEMI door-to-balloon time >90 min increases mortality by 40%

Statistic 54

Aspirin reduces vascular mortality by 23% in CHD patients

Statistic 55

Statin therapy lowers CHD mortality by 20-30%

Statistic 56

Beta-blockers post-MI reduce mortality by 23%

Statistic 57

ACE inhibitors reduce mortality by 20% in post-MI patients

Statistic 58

Primary PCI for STEMI reduces mortality to 3-5% vs 7-10% thrombolysis

Statistic 59

Cardiac rehab reduces mortality by 20-30% post-event

Statistic 60

ICD implantation reduces sudden death by 30% in high-risk CHD

Statistic 61

CABG vs PCI: 5-year mortality 13.7% vs 19.4% in diabetes

Statistic 62

Radial access PCI reduces mortality by 50% vs femoral

Statistic 63

Optimal medical therapy alone: 2.4% annual mortality

Statistic 64

In the United States, approximately 20.1 million adults aged 18 and older have coronary heart disease (CHD)

Statistic 65

Globally, cardiovascular diseases (CVDs) account for 17.9 million deaths annually, with ischemic heart disease (a form of CHD) being the leading cause at 8.9 million deaths

Statistic 66

The age-adjusted prevalence of CHD in US adults is 6.7% overall, rising to 24.0% in those aged 65 and older

Statistic 67

In Europe, the incidence of acute myocardial infarction (key CHD event) is 1.29 million cases per year

Statistic 68

Among US men, CHD prevalence is 7.8%, compared to 5.8% in women

Statistic 69

In India, CHD prevalence in urban populations is 7-13%, doubling every decade after age 40

Statistic 70

UK has about 2.3 million people living with CHD

Statistic 71

In Australia, 1 in 20 adults (over 500,000) have CHD

Statistic 72

China reports over 11 million CHD patients, with incidence increasing by 8.4% annually

Statistic 73

In the US, non-Hispanic Black adults have a CHD prevalence of 6.1%, higher than non-Hispanic White at 6.5% when adjusted

Statistic 74

Brazil's CHD prevalence is around 4.5% in adults over 40

Statistic 75

In Japan, CHD incidence is lower at 100 per 100,000 person-years compared to Western countries

Statistic 76

South Africa shows CHD prevalence of 8.6% in urban black populations

Statistic 77

Canada reports 1.6 million adults with diagnosed ischemic heart disease

Statistic 78

In Germany, over 2.3 million people suffer from CHD

Statistic 79

Mexico's CHD prevalence is 3.4% in adults, rising with urbanization

Statistic 80

Russia has high CHD incidence at 500-600 per 100,000 annually

Statistic 81

In Saudi Arabia, CHD prevalence among adults is 9.6%

Statistic 82

New Zealand Maori have CHD prevalence 1.5 times higher than Europeans

Statistic 83

In Sweden, CHD affects 4% of the population

Statistic 84

Turkey reports CHD prevalence of 4.1% in adults over 40

Statistic 85

In the US, rural areas have 20% higher CHD prevalence than urban

Statistic 86

Egypt shows 10.1% CHD prevalence in urban areas

Statistic 87

In France, 3.5 million people have CHD

Statistic 88

Nigeria's urban CHD prevalence is 8.3%

Statistic 89

In Italy, CHD incidence is 200 per 100,000

Statistic 90

US Hispanics have CHD prevalence of 5.9%

Statistic 91

In Poland, 2.5% of adults have diagnosed CHD

Statistic 92

Vietnam reports rising CHD incidence to 150 per 100,000

Statistic 93

In the US, CHD prevalence increases from 1.2% in 18-44 year olds to 18.2% in 75+

Statistic 94

Smoking increases CHD risk by 2-4 times

Statistic 95

High blood pressure contributes to 50% of all CHD cases globally

Statistic 96

Diabetes doubles the risk of CHD, with 65% of diabetics dying from heart disease or stroke

Statistic 97

Obesity raises CHD risk by 50-100% in adults

Statistic 98

High LDL cholesterol levels increase CHD risk by 3-fold when above 190 mg/dL

Statistic 99

Physical inactivity accounts for 6% of the global CHD burden

Statistic 100

Family history doubles CHD risk if first-degree relative affected before age 60

Statistic 101

Men have 50% higher CHD risk than premenopausal women

Statistic 102

Chronic kidney disease increases CHD risk 10-50 times

Statistic 103

Air pollution (PM2.5) exposure raises CHD risk by 10-20% per 10 ug/m3 increase

Statistic 104

Excessive alcohol (>14 drinks/week) increases CHD risk by 20%

Statistic 105

Low socioeconomic status triples CHD risk due to multiple factors

Statistic 106

Hyperhomocysteinemia (>15 umol/L) associated with 2.5-fold CHD risk

Statistic 107

Shift work increases CHD risk by 40%

Statistic 108

Depression raises CHD risk by 30-64%

Statistic 109

HIV infection increases CHD risk 1.5-2 times due to inflammation

Statistic 110

Psoriasis patients have 50% higher CHD risk

Statistic 111

Rheumatoid arthritis doubles CHD risk

Statistic 112

Sleep apnea increases CHD risk by 30-140%

Statistic 113

High stress (job strain) linked to 20% higher CHD risk

Statistic 114

Oral contraceptive use in smokers over 35 increases CHD risk 4-fold

Statistic 115

Gout associated with 1.6-2.3 times higher CHD risk

Statistic 116

High triglycerides (>200 mg/dL) raise CHD risk by 30%

Statistic 117

Sedentary behavior >8 hours/day increases CHD risk by 147%

Statistic 118

Erectile dysfunction predicts CHD risk with 44% event rate in 2 years

Statistic 119

Metabolic syndrome increases CHD risk 2-3 fold

Statistic 120

Non-alcoholic fatty liver disease raises CHD risk by 64%

Statistic 121

Chronic obstructive pulmonary disease (COPD) doubles CHD risk

Statistic 122

Polycystic ovary syndrome (PCOS) increases CHD risk 2-7 fold

Statistic 123

Inflammatory bowel disease elevates CHD risk by 20-50%

1/123

Sources

Trusted by 500+ publications

+497

While coronary heart disease claims a staggering 8.9 million lives globally each year, its silent grip extends far beyond a single statistic, weaving a complex and costly web of risk factors, disparities, and human impact that touches every corner of our world.

Key Takeaways

In the United States, approximately 20.1 million adults aged 18 and older have coronary heart disease (CHD)
Globally, cardiovascular diseases (CVDs) account for 17.9 million deaths annually, with ischemic heart disease (a form of CHD) being the leading cause at 8.9 million deaths
The age-adjusted prevalence of CHD in US adults is 6.7% overall, rising to 24.0% in those aged 65 and older
Smoking increases CHD risk by 2-4 times
High blood pressure contributes to 50% of all CHD cases globally
Diabetes doubles the risk of CHD, with 65% of diabetics dying from heart disease or stroke
In the US, CHD caused 382,897 deaths in 2022, accounting for 1 in 5 deaths
Globally, ischemic heart disease mortality is 16% of all deaths, or 9 million annually
Post-myocardial infarction 1-year mortality is 10-15% in developed countries
US spends $219 billion annually on CHD
Global CVD economic burden $1 trillion/year, half from CHD
Lost productivity from CHD: $101 billion/year in US

CHD is a widespread global health crisis affecting millions worldwide.

Economic and Social Impact

US spends $219 billion annually on CHD
Global CVD economic burden $1 trillion/year, half from CHD
Lost productivity from CHD: $101 billion/year in US
CABG costs average $123,000 per patient in US
PCI procedure costs $20,000-$50,000
Medicare CHD spending $80 billion/year
Work absenteeism from CHD: 5.5 million lost days/year UK
Informal caregiving for CHD patients costs $30 billion/year US
Disability claims from CHD: 20% of all cardiovascular
Hospitalizations for CHD: 1.2 million/year US, costing $75 billion
Low-income CHD patients have 2x higher hospitalization rates
Gender pay gap widens post-CHD by 10-20% for women
CHD reduces life expectancy by 5-10 years
Social isolation increases CHD hospitalization by 68%
Employer costs for employee CHD: $1,500 higher annually
Global CHD productivity losses $3.7 trillion 2011-2030
Nursing home admissions post-CHD double costs by $50,000/year
Racial disparities: Black CHD costs 25% higher per case
Telemedicine for CHD saves $2,000 per patient annually
Smoking-related CHD costs $184 billion/year US
Obesity-attributable CHD costs $192 billion/year globally
Cardiac rehab ROI: $2.33 saved per $1 spent
Statins prevent $13,000 cost per MI avoided
Aspirin therapy saves $20-40 per patient/year

Economic and Social Impact Interpretation

While the world bleeds over a trillion dollars a year to prop up faltering hearts, we somehow find the pennies for aspirin but consistently miss the artery for preventive investment.

Mortality and Morbidity

In the US, CHD caused 382,897 deaths in 2022, accounting for 1 in 5 deaths
Globally, ischemic heart disease mortality is 16% of all deaths, or 9 million annually
Post-myocardial infarction 1-year mortality is 10-15% in developed countries
US men have age-adjusted CHD death rate of 90.9 per 100,000, women 55.8
In low-income countries, CHD mortality is rising 2% per year
Heart failure post-CHD affects 6.2 million US adults, with 50% 5-year mortality
Recurrent MI occurs in 10-20% within 1 year post-event
CHD patients have 2-4 times higher stroke risk
In-hospital mortality for STEMI is 5-10%, NSTEMI 3-5%
Black Americans have 30% higher CHD mortality than Whites
Global disability-adjusted life years (DALYs) from ischemic heart disease: 182 million
5-year survival post-CHD diagnosis is 80-90% with treatment
Women with CHD have 50% higher mortality post-MI than men
Rural US CHD mortality 20% higher than urban
Untreated hypertension leads to 50% CHD mortality increase
Sudden cardiac death accounts for 50% of CHD deaths
Post-CABG 10-year mortality is 20-30%
Diabetes doubles CHD mortality risk
Age 75+ has CHD mortality rate >500 per 100,000
Global CHD years of life lost (YLL): 197 million annually
PCI in-hospital mortality <1% for elective, 2-3% urgent
Chronic total occlusion increases annual mortality by 2-3%
Multi-vessel disease mortality 2x single-vessel
Smoking cessation reduces CHD mortality by 36% in 5 years
Left ventricular ejection fraction <35% post-MI: 20-40% 1-year mortality
Atrial fibrillation in CHD patients doubles mortality risk
PCI vs medical therapy mortality similar at 5 years (16.7% vs 18.2%)
CABG 30-day mortality 2-3%
STEMI door-to-balloon time >90 min increases mortality by 40%
Aspirin reduces vascular mortality by 23% in CHD patients
Statin therapy lowers CHD mortality by 20-30%
Beta-blockers post-MI reduce mortality by 23%
ACE inhibitors reduce mortality by 20% in post-MI patients
Primary PCI for STEMI reduces mortality to 3-5% vs 7-10% thrombolysis
Cardiac rehab reduces mortality by 20-30% post-event
ICD implantation reduces sudden death by 30% in high-risk CHD
CABG vs PCI: 5-year mortality 13.7% vs 19.4% in diabetes
Radial access PCI reduces mortality by 50% vs femoral
Optimal medical therapy alone: 2.4% annual mortality

Mortality and Morbidity Interpretation

The sheer scale of coronary heart disease's toll—from claiming one in five American lives to its relentless global rise and stark disparities in survival—is a solemn reminder that while our modern arsenal of pills and procedures can tame it, this remains a formidable and deeply unfair predator of human vitality.

Prevalence and Incidence

In the United States, approximately 20.1 million adults aged 18 and older have coronary heart disease (CHD)
Globally, cardiovascular diseases (CVDs) account for 17.9 million deaths annually, with ischemic heart disease (a form of CHD) being the leading cause at 8.9 million deaths
The age-adjusted prevalence of CHD in US adults is 6.7% overall, rising to 24.0% in those aged 65 and older
In Europe, the incidence of acute myocardial infarction (key CHD event) is 1.29 million cases per year
Among US men, CHD prevalence is 7.8%, compared to 5.8% in women
In India, CHD prevalence in urban populations is 7-13%, doubling every decade after age 40
UK has about 2.3 million people living with CHD
In Australia, 1 in 20 adults (over 500,000) have CHD
China reports over 11 million CHD patients, with incidence increasing by 8.4% annually
In the US, non-Hispanic Black adults have a CHD prevalence of 6.1%, higher than non-Hispanic White at 6.5% when adjusted
Brazil's CHD prevalence is around 4.5% in adults over 40
In Japan, CHD incidence is lower at 100 per 100,000 person-years compared to Western countries
South Africa shows CHD prevalence of 8.6% in urban black populations
Canada reports 1.6 million adults with diagnosed ischemic heart disease
In Germany, over 2.3 million people suffer from CHD
Mexico's CHD prevalence is 3.4% in adults, rising with urbanization
Russia has high CHD incidence at 500-600 per 100,000 annually
In Saudi Arabia, CHD prevalence among adults is 9.6%
New Zealand Maori have CHD prevalence 1.5 times higher than Europeans
In Sweden, CHD affects 4% of the population
Turkey reports CHD prevalence of 4.1% in adults over 40
In the US, rural areas have 20% higher CHD prevalence than urban
Egypt shows 10.1% CHD prevalence in urban areas
In France, 3.5 million people have CHD
Nigeria's urban CHD prevalence is 8.3%
In Italy, CHD incidence is 200 per 100,000
US Hispanics have CHD prevalence of 5.9%
In Poland, 2.5% of adults have diagnosed CHD
Vietnam reports rising CHD incidence to 150 per 100,000
In the US, CHD prevalence increases from 1.2% in 18-44 year olds to 18.2% in 75+

Prevalence and Incidence Interpretation

The human heart, a tireless and often underappreciated organ, finds itself in a grim global popularity contest it never asked to win, with millions of lives and a staggering array of national statistics tragically voting for its failure.

Risk Factors

Smoking increases CHD risk by 2-4 times
High blood pressure contributes to 50% of all CHD cases globally
Diabetes doubles the risk of CHD, with 65% of diabetics dying from heart disease or stroke
Obesity raises CHD risk by 50-100% in adults
High LDL cholesterol levels increase CHD risk by 3-fold when above 190 mg/dL
Physical inactivity accounts for 6% of the global CHD burden
Family history doubles CHD risk if first-degree relative affected before age 60
Men have 50% higher CHD risk than premenopausal women
Chronic kidney disease increases CHD risk 10-50 times
Air pollution (PM2.5) exposure raises CHD risk by 10-20% per 10 ug/m3 increase
Excessive alcohol (>14 drinks/week) increases CHD risk by 20%
Low socioeconomic status triples CHD risk due to multiple factors
Hyperhomocysteinemia (>15 umol/L) associated with 2.5-fold CHD risk
Shift work increases CHD risk by 40%
Depression raises CHD risk by 30-64%
HIV infection increases CHD risk 1.5-2 times due to inflammation
Psoriasis patients have 50% higher CHD risk
Rheumatoid arthritis doubles CHD risk
Sleep apnea increases CHD risk by 30-140%
High stress (job strain) linked to 20% higher CHD risk
Oral contraceptive use in smokers over 35 increases CHD risk 4-fold
Gout associated with 1.6-2.3 times higher CHD risk
High triglycerides (>200 mg/dL) raise CHD risk by 30%
Sedentary behavior >8 hours/day increases CHD risk by 147%
Erectile dysfunction predicts CHD risk with 44% event rate in 2 years
Metabolic syndrome increases CHD risk 2-3 fold
Non-alcoholic fatty liver disease raises CHD risk by 64%
Chronic obstructive pulmonary disease (COPD) doubles CHD risk
Polycystic ovary syndrome (PCOS) increases CHD risk 2-7 fold
Inflammatory bowel disease elevates CHD risk by 20-50%

Risk Factors Interpretation

The data paints a clear and grim portrait: from the air we breathe and the jobs we hold to the conditions we inherit and the choices we make, our modern world is a minefield of multiplicative threats conspiring to break our hearts.

Sources & References

Logos provided by Logo.dev